SB 2499 In Committee
TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Sign in to read the full text
The document summary and details above are public. The full text is available to signed-in accounts.